MFN2 role in cancer is still controversial, acting either as an onco-suppressor or oncogenic factor, depending on the tumour type and the tissue; however, in many solid tumours, MFN2 shows an anticancer function, inducing cell apoptosis and inhibiting proliferation through Bax-mediated apoptosis [31, 32]. This evidence concerns the gene BAX and neoplasm.